[Advantages and disadvantages of the medical treatment of Zollinger-Ellison syndrome].
Cadiot
G
G
Service d'Hépato-Gastroentérologie, Hôpital Bichat-Claude Bernard, Paris, France.
Cadranel
J F
JF
Mignon
M
M
Bonfils
S
S
D002455:Cell Division; D004759:Enterochromaffin Cells / Q000473:pathology; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D013270:Stomach / Q000473:pathology; D015043:Zollinger-Ellison Syndrome / Q000473:pathology / Q000628:therapy*
D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D015282:Octreotide
Avantages et inconvénients du traitement médical du syndrome de Zollinger Ellison.